HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study.
Publication
, Journal Article
Flynn, KE; Clements, J; DeMairo, K; Hiller, J; Wei, D; Hazra, NC; Constantinescu, C; Meng, Y; Latremouille-Viau, D; Jadhav, K; Marquez, G ...
Published in: J Natl Compr Canc Netw
March 28, 2025
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 28, 2025
Volume
23
Issue
3.5
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Flynn, K. E., Clements, J., DeMairo, K., Hiller, J., Wei, D., Hazra, N. C., … Schoenbeck, K. (2025). HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study. J Natl Compr Canc Netw, 23(3.5). https://doi.org/10.6004/jnccn.2024.7251
Flynn, Kathryn E., Joan Clements, Karen DeMairo, Jennifer Hiller, David Wei, Nisha C. Hazra, Cristina Constantinescu, et al. “HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study.” J Natl Compr Canc Netw 23, no. 3.5 (March 28, 2025). https://doi.org/10.6004/jnccn.2024.7251.
Flynn KE, Clements J, DeMairo K, Hiller J, Wei D, Hazra NC, et al. HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5).
Flynn, Kathryn E., et al. “HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study.” J Natl Compr Canc Netw, vol. 23, no. 3.5, Mar. 2025. Pubmed, doi:10.6004/jnccn.2024.7251.
Flynn KE, Clements J, DeMairo K, Hiller J, Wei D, Hazra NC, Constantinescu C, Meng Y, Latremouille-Viau D, Jadhav K, Marquez G, Yang D, Damon A, Sadek I, Guérin A, Schoenbeck K. HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5).
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 28, 2025
Volume
23
Issue
3.5
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis